CID 135783355

Schembl1522284

Structural Information

Molecular Formula
C21H21N5O6S2
SMILES
CS(=O)(=O)NC1=CC2=C(C=C1)NC(=NS2(=O)=O)C3=C(C4=CC=CC=C4N(C3=O)NC5CCC5)O
InChI
InChI=1S/C21H21N5O6S2/c1-33(29,30)24-13-9-10-15-17(11-13)34(31,32)25-20(22-15)18-19(27)14-7-2-3-8-16(14)26(21(18)28)23-12-5-4-6-12/h2-3,7-12,23-24,27H,4-6H2,1H3,(H,22,25)
InChIKey
RJCFDNPXJHECBO-UHFFFAOYSA-N
Compound name
N-[3-[1-(cyclobutylamino)-4-hydroxy-2-oxoquinolin-3-yl]-1,1-dioxo-4H-1lambda6,2,4-benzothiadiazin-7-yl]methanesulfonamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

13
Patents

503.09332 Da
Monoisotopic Mass

0.8
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 504.10060 209.3
[M+Na]+ 526.08254 213.5
[M-H]- 502.08604 211.3
[M+NH4]+ 521.12714 207.0
[M+K]+ 542.05648 210.4
[M+H-H2O]+ 486.09058 193.3
[M+HCOO]- 548.09152 211.6
[M+CH3COO]- 562.10717 239.4
[M+Na-2H]- 524.06799 215.6
[M]+ 503.09277 218.8
[M]- 503.09387 218.8
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe